Brent J. Yamamoto, Ph.D.
Affiliations: | 2006 | Washington State University, Pullman, WA, United States |
Google:
"Brent Yamamoto"Mean distance: 20.78 (cluster 32)
Parents
Sign in to add mentor| Joseph W. Harding | grad student | 2006 | WSU | |
| (Norleual, an angiotensin IV receptor ligand and c-Met antagonist.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kawas LH, Church KJ, Lange M, et al. (2014) Abstract 729: Norleual a hepatocyte growth factor/c-Met inhibitor blocks malignant phenotypes in cancerous cells Cancer Research. 74: 729-729 |
| Kawas LH, McCoy AT, Yamamoto BJ, et al. (2012) Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48 |
| Kawas LH, Yamamoto BJ, Wright JW, et al. (2011) Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. The Journal of Pharmacology and Experimental Therapeutics. 339: 509-18 |
| Kawas LH, Harding JW, Yamamoto BJ, et al. (2011) Abstract 1356: The Hinge (linker) region of the Hepatocyte Growth Factor (HGF) peptide sequence can act as Hepatocyte Growth Factor/c-Met inhibitor Cancer Research. 71: 1356-1356 |
| Yamamoto BJ, Elias PD, Masino JA, et al. (2010) The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 333: 161-73 |
| Wright JW, Yamamoto BJ, Harding JW. (2008) Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Progress in Neurobiology. 84: 157-81 |